Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Bio-Techne — Bio-Techne Diagnostics

Tracked across 7 events · 110 articles · First seen Apr 16, 2026 · Last active Sep 22, 2026

Sentiment
39
Attention
8
Events
7
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Impact: Bio-Techne — Bio-Techne Diagnostics introduced a streamlined brand architecture to better organize its product portfolios, aiming to enhance customer navigation and accelerate scientific progress. This move is expected to strengthen its market position.
Apr 16, 2026 · 6 articles
8 75
Business
Impact: Bio-Techne — Bio-Techne Diagnostics is being acquired by Merck Group for $11.3 billion, representing a significant premium for its shareholders. The company's portfolio of life science reagents, analytical instruments, and clinical diagnostics will be integrated into Merck Group's life sciences division, expanding its global reach and innovation capabilities.
Jun 25, 2026 · 21 articles
4 75
Tech
Impact: Bio-Techne — Bio-Techne Diagnostics Corporation, a global life sciences company, partnered with Refeyn to launch an integrated workflow for characterizing bispecific antibodies and biosimilars, enhancing its product offerings and market position in biotherapeutics.
Jun 04, 2026 · 7 articles
2 15
Business
Impact: Bio-Techne — Bio-Techne Diagnostics is the company launching the expanded protein portfolio, which enhances its product offering and competitive position in cell therapy and advanced cell culture markets.
Jul 08, 2026 · 7 articles
1 15
Business
Bio-Techne — Bio-Techne Diagnostics Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, announced the opening of a new Customer Experience Center in Dusseldorf, Germany. The flagship facility is designed…
Impact: Bio-Techne — Bio-Techne Diagnostics is the sole actor in this event, opening the Dusseldorf Customer Experience Center to deepen European customer engagement and support future sales growth.
Sep 22, 2026 · 6 articles
8 70
Business
Impact: Bio-Techne — Bio-Techne Diagnostics jumped after Merck Group agreed to acquire it for $11.3 billion.
Jun 24, 2026 · 57 articles
1 0
Business
Impact: As a tenant, Bio-Techne — Bio-Techne Diagnostics leases property within the fund, providing rental income but with no material effect on its business.
Aug 21, 2026 · 6 articles
90 Bio-Techne — Bio-Techne Diagnostics opened Customer Experience CenterBio-Techne Opens...
ERGEN INTELLIGENCE
Track Bio-Techne — Bio-Techne Diagnostics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.